Mechanism of Qianlie Zhitong Formula Against Chronic Prostatitis Based on Proteomics and Metabolomics.
4 affiliations
- 1WANG Qi Academy, National Institute of TCM Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing, China.
- 2Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
- 3Beijing University of Chinese Medicine, Beijing, China.
- 4School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Abstract
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a prevalent pelvic pain disorder in men, yet effective pharmacotherapies remain limited. Emerging evidence suggests that oxidative stress and dysregulated iron metabolism contribute to the pathogenesis of CP/CPPS, with ferroptosis increasingly implicated in CP/CPPS-related pathology. Qianlie Zhitong Formula (QLZTF) has shown therapeutic potential in treating CP/CPPS; however, its underlying mechanisms remain incompletely understood. This study integrated proteomics, metabolomics, and in vivo experiments to investigate the therapeutic mechanisms of QLZTF. A carrageenan-induced rat model was established, and rats were randomly assigned to five groups: control, model, Qianliekang, low-dose QLZTF, and high-dose QLZTF. QLZTF significantly reduced inflammatory cytokines (TNF-α, IL-6, and IL-1β), alleviated pain responses, and ameliorated prostate tissue injury. Proteomic analysis identified BCAT2, ALDH1B1, and ALDH2 as significantly upregulated proteins closely associated with ferroptosis. KEGG enrichment analysis of both proteomic and metabolomic data revealed that pantothenate and CoA biosynthesis and branched-chain amino acid (BCAA) degradation pathways were significantly enriched. Integrated analysis indicated that QLZTF synergistically regulates these pathways, activates the BCAT2/ALDH axis, and inhibits ferroptosis, thereby alleviating inflammation, pain, and fibrosis in CP/CPPS. This study provides the first multiomics evidence for the anti-ferroptotic mechanism of QLZTF.
Related
- Mechanism of Glycyrrhiza and glycyrrhetinic acid in cisplatin-induced acute kidney injury: a proteomics and metabolomics study
- Integrated network pharmacology, in vivo experiment, computational biology, and metabolomics to explore the mechanism of astragaloside IV against spinal cord injury
- Insights into potential multi-target protective effects of Tanshinone IIA in steroid-induced osteonecrosis of the femoral head: evidence from integrated metabolomics and proteomics
- Association of Frailty Status with Semi-Targeted Metabolomics and Untargeted Proteomics in Older Adults Referred for Physical Therapy in a Geriatric Clinic
- Volatile flavoromics and metabolomics reveal quality evolution mechanism of Zhenghe white peony tea during storage
BibTeX
@article{dong2026mechanism,
title = {{Mechanism of Qianlie Zhitong Formula Against Chronic Prostatitis Based on Proteomics and Metabolomics.}},
author = {Lidan Dong and Linhan Chang and Caijia Song and Jialin Yan and Tiantong Shen and Zhen Ding and Yunyu Liu and Chenglong Zheng and Yanfei Zheng and Qi Wang},
journal = {Chemical biology \& drug design},
year = {2026},
month = oct,
doi = {10.1111/cbdd.70401},
url = {https://europepmc.org/article/MED/42897762},
note = {CC BY},
}
RIS
TY - JOUR
TI - Mechanism of Qianlie Zhitong Formula Against Chronic Prostatitis Based on Proteomics and Metabolomics.
AU - Lidan Dong
AU - Linhan Chang
AU - Caijia Song
AU - Jialin Yan
AU - Tiantong Shen
AU - Zhen Ding
AU - Yunyu Liu
AU - Chenglong Zheng
AU - Yanfei Zheng
AU - Qi Wang
PY - 2026
DA - 2026/10/01
JO - Chemical biology & drug design
DO - 10.1111/cbdd.70401
UR - https://europepmc.org/article/MED/42897762
AB - Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a prevalent pelvic pain disorder in men, yet effective pharmacotherapies remain limited. Emerging evidence suggests that oxidative stress and dysregulated iron metabolism contribute to the pathogenesis of CP/CPPS, with ferroptosis increasingly implicated in CP/CPPS-related pathology. Qianlie Zhitong Formula (QLZTF) has shown therapeutic potential in treating CP/CPPS; however, its underlying mechanisms remain incompletely understood. This study integrated proteomics, metabolomics, and in vivo experiments to investigate the therapeutic mechanisms of QLZTF. A carrageenan-induced rat model was established, and rats were randomly assigned to five groups: control, model, Qianliekang, low-dose QLZTF, and high-dose QLZTF. QLZTF significantly reduced inflammatory cytokines (TNF-α, IL-6, and IL-1β), alleviated pain responses, and ameliorated prostate tissue injury. Proteomic analysis identified BCAT2, ALDH1B1, and ALDH2 as significantly upregulated proteins closely associated with ferroptosis. KEGG enrichment analysis of both proteomic and metabolomic data revealed that pantothenate and CoA biosynthesis and branched-chain amino acid (BCAA) degradation pathways were significantly enriched. Integrated analysis indicated that QLZTF synergistically regulates these pathways, activates the BCAT2/ALDH axis, and inhibits ferroptosis, thereby alleviating inflammation, pain, and fibrosis in CP/CPPS. This study provides the first multiomics evidence for the anti-ferroptotic mechanism of QLZTF.
SN - 1747-0277
SN - 1747-0285
ER -